News

Rises in disease prevalence in UK

27-Apr-07

Disease prevalence recorded by GPs in the quality framework has risen by up to 14 per cent since it began in 2004/5, GP can reveal.

Provisional disease prevalence figures for 2006/7 in England from the quality management and analysis system (QMAS) also contain the first data on domains added in 2006/7.

Prevalence of hypothyroidism recorded by GPs has risen faster than any other domain, up 14 per cent from 2.18 to 2.49 per cent of the population.

Recorded prevalence of stroke, diabetes, and hypertension rose by around 10 per cent, while COPD increased by 5 per cent.

Prevalence of epilepsy recorded by GP practices is unchanged, while prevalence of CHD and asthma have dropped.

The average rise across these domains is around 6 per cent.

GPC deputy chairman Dr Laurence Buckman said prevalence had not risen, but GPs were working harder to identify disease.

‘When you start case-finding systematically, as the quality framework incentivises you to, you find more,’ he said.

Dr Buckman predicted preva-lence recorded by GP practices would continue to rise in most categories for around five years: ‘After five years the prevalence will flatten out — if it changes then, something has happened.’

The QMAS data show that practices now have 0.9 per cent of their patients on cancer registers, compared to 0.51 per cent in 2004/5.

However, Swindon GP Dr Gavin Jamie explained: ‘The figure is a running total which shows all patients added since 2003.’

Mental health prevalence has increased from 0.55 per cent in 2004/5 to 0.72 per cent in 2006/7, but the criteria have changed.

In the first two years of the quality framework, practices’ registers showed patients with a severe mental illness. But the register now shows patients who have had a psychotic episode or bipolar disorder at any point in their life.

Prevalence data for domains added to the quality framework for the first time in 2006/7 has also been obtained by GP.

A total of 7 per cent of patients are on depression registers — this includes patients who have been diagnosed with depression in the last year and assessed.

GPs recorded that 19.56 per cent of their populations smoke, 0.26 per cent have learning disabilities, 7.22 per cent are obese, 1.3 per cent have AF and 0.4 per cent have dementia.

QMAS shows prevalence of chronic kidney disease (CKD) as around 2.24 per cent, but experts believe this under-represents the true level of disease by around 50 per cent (GP, 2 March).

What do you think? Email us your comment GPletters@haymarket.com

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

RCGP Curriculum - 15.8 Respiratory Problems

This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more

RCGP Curriculum - 15.10 Skin Problems

This section of our curriculum guide refers to statement 15.10, Skin Problems, produced by the Royal... Read more

RCGP Curriculum - 15.6 Metabolic Problems

This section of our curriculum guide refers to statement 15.6, Metabolic Problems, produced by the R... Read more

Show all articles

 

Latest Clinical Articles

Chronic constipation

Contributed by Dr Naila Arebi, consultant gastroenterologist, St Mark's Hospital, Harrow, and The Lo... Read more

Sexually transmitted infections

Contributed by Dr Alan McOwan, lead clinician, Victoria Clinic for HIV and Sexual Health, London. Read more

Pemphigus

Contributed by Dr Sacha Goolamali, dermatology specialist registrar and Dr Rachael Morris-Jones, con... Read more

Show all clinical articles

MIMS Product News

New drug - NuvaRing

A non-daily, low oestrogen contraceptive utilising a vaginal delivery system. Read more

New drug - Siklos

Nordic Pharma has launched Siklos (hydroxycarbamide) for the prevention of recurrent painful vaso-oc... Read more

New drug - Bridion

Schering-Plough has launched Bridion (sugammadex) for the reversal of neuromuscular blockade induced... Read more

Jobs

 

Job of the Week